Probing Disaccharide Binding to Triplatin As Models for Tumor Cell Heparan Sulfate (GAG) Interactions

In this study, we have used [H, N] NMR spectroscopy to investigate the interactions of the trinuclear platinum anticancer drug triplatin () (1,0,1 or BBR3464) with site-specific sulfated and carboxylated disaccharides. Specifically, the disaccharides GlcNS(6)-GlcA () and GlcNS(6)-IdoA(2S) () are useful models of longer-chain glycosaminoglycans (GAGs) such as heparan sulfate (HS). For both the reactions of N with and , equilibrium conditions were achieved more slowly (65 h) compared to the reaction with the monosaccharide GlcNS(6S) (9 h). The data suggest both carboxylate and sulfate binding of disaccharide to the Pt with the sulfato species accounting for <1% of the total species at equilibrium. The rate constant for sulfate displacement of the aqua ligand () is 4 times higher than the analogous rate constant for carboxylate displacement (). There are marked differences in the equilibrium concentrations of the chlorido, aqua, and carboxy-bound species for reactions with the two disaccharides, notably a significantly higher concentration of carboxylate-bound species for , where sulfate-bound species were barely detectable. The trend mirrors that reported for the corresponding dinuclear platinum complex 1,1/, where the rate constant for sulfate displacement of the aqua ligand was 3 times higher than that for acetate. Also similar to what we observed for the reactions of 1,1/ with the simple anions, aquation of the sulfato group is rapid, and the rate constant is 3 orders of magnitude higher than that for displacement of the carboxylate (). Molecular dynamics calculations suggest that extra hydrogen-bonding interactions with the more sulfated disaccharide may prevent or diminish sulfate binding of the triplatin moiety. The overall results suggest that Pt- donor interactions should be considered in any full description of platinum complex cellular chemistry.